APA

Mascarenhas J., Sandy L., Lu M., Yoon J., Petersen B., Zhang D., Ye F., Newsom C., Najfeld V., Hochman T., Goldberg J. D. & Hoffman R. (20170728). A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF). : Leukemia research.

Chicago

Mascarenhas John, Sandy Lonette, Lu Min, Yoon James, Petersen Bruce, Zhang David, Ye Fei, Newsom Carrie, Najfeld Vesna, Hochman Tsivia, Goldberg Judith D and Hoffman Ronald. 20170728. A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF). : Leukemia research.

Harvard

Mascarenhas J., Sandy L., Lu M., Yoon J., Petersen B., Zhang D., Ye F., Newsom C., Najfeld V., Hochman T., Goldberg J. D. and Hoffman R. (20170728). A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF). : Leukemia research.

MLA

Mascarenhas John, Sandy Lonette, Lu Min, Yoon James, Petersen Bruce, Zhang David, Ye Fei, Newsom Carrie, Najfeld Vesna, Hochman Tsivia, Goldberg Judith D and Hoffman Ronald. A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF). : Leukemia research. 20170728.